{"title": "TICOVAC Quick Finder", "author": null, "url": "https://www.pfizermedicalinformation.com/en-us/node/906411/pi_section/field_spl_highlights", "hostname": "pfizermedicalinformation.com", "description": "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular", "sitename": "pfizermedicalinformation.com", "date": "2023-07-01", "cleaned_text": "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for injection Initial U.S. Approval: 2021 INDICATIONS AND USAGE TICOVAC is a vaccine indicated for active immunization to prevent tick-borne encephalitis (TBE). TICOVAC is approved for use in individuals 1 year of age and older. ( DOSAGE AND ADMINISTRATION For intramuscular use only. Primary Vaccination: Three doses ( A booster dose (fourth dose) may be given at least 3 years after completion of the primary immunization series if ongoing exposure or re-exposure to tick-borne encephalitis virus (TBEV) is expected. DOSAGE FORMS AND STRENGTHS Suspension for injection supplied as a 0.25 mL or 0.5 mL single-dose in pre-filled syringes. ( CONTRAINDICATIONS ADVERSE REACTIONS The most common adverse reactions are as follows: To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or VAERS at 1-800-822-7967 or See 17 for PATIENT COUNSELING INFORMATION. Revised: 7/2023 If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents. TICOVAC Highlights (tick-borne encephalitis vaccine,whole virus, inactivated) Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine. *Contact Medical Information. Submit a medical question for Pfizer prescription products. To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: [Pfizer Safety Reporting Site](https://www.pfizersafetyreporting.com/) *If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site. If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at [(800) "}